Worst Pills - generic-tadalafil.info
rimonabant (ZIMULTI)

Additional Information from Public Citizen

Search results below include Additional Information from Public Citizen where your selected drug is a primary subject of discussion
  • [hide all summaries]
    The European drug regulatory authority should immediately remove from the European market the arthritis drug etoricoxib (Arcoxia) and the anti-obesity drug rimonabant (Accomplia), according to a letter sent by Public Citizen to the European Medicines Agency (EMEA) today.
  • [hide all summaries]
    The Food and Drug Administration (FDA) should not approve the new diet drug rimonabant (marketed as Acomplia in Europe and known as Zimulti in the U.S.) because it produces only modest weight loss and has been shown to produce serious physical and psychological adverse effects, according to Public Citizen testimony before an FDA advisory committee meeting today.

SHOW secondary search results for rimonabant (ZIMULTI)